Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Price:
180.62
USD
-0.65%
Market Closed
Market Cap:
$11.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
IE |
|
Daifuku Co Ltd
TSE:6383
|
JP |
|
Kawata Mfg. Co Ltd
TSE:6292
|
JP |
|
C
|
Carzo Holdings Bhd
KLSE:CARZO
|
MY |
|
K
|
Kredyt Inkaso SA
WSE:KRI
|
PL |
|
Brass Corp
TSE:2424
|
JP |
|
Sensys Gatso Group AB
STO:SENS
|
SE |
|
Phoenix Group Holdings PLC
LSE:PHNX
|
UK |
Relative Value
The Relative Value of one
JAZZ
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 180.62 USD,
Jazz Pharmaceuticals PLC
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JAZZ Relative Value
HIDDEN
Multiples Across Competitors
JAZZ Competitors Multiples
Jazz Pharmaceuticals PLC Competitors
Jazz Pharmaceuticals PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IE |
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
11.1B USD | 2.6 | -31.2 | 10.7 | 25.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28 | 15.6 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.5 | 12.7 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
